Moderna Scales Back Its Vaccine Ambitions as COVID Jab Revenue Collapses – Ben Kew

 Moderna vaccine The pharmaceutical giant Moderna is scaling back its ambitions to develop new vaccines after demand for its dodgy COVID-19 jab collapsed. According to Axios, the company has seen its revenue from the COVID-19 vaccines plunge over the past few years and can no longer afford to research new vaccines. The report states: Moderna is dialing back its plans for new vaccines, shelving several key projects as it grapples with a sharp slowdown in COVID shot sales. … [The company] plans to “slow down the pace of new R&D investment, and build our commercial business,” CEO Stéphane Bancel said… — Source: The Gateway Pundit – Read More